Summit Therapeutics
SMMT
#1342
Rank
HK$102.39 B
Marketcap
HK$138.85
Share price
-2.88%
Change (1 day)
647.04%
Change (1 year)

Summit Therapeutics (SMMT) - Cash on Hand

Cash on Hand as of September 2024 : HK$3.78 Billion

According to Summit Therapeutics 's latest financial reports the company has HK$3.78 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Summit Therapeutics - Cash on Hand chart (from 2020 to 2020)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31HK$1.45 B-46.6%
2022-12-31HK$2.72 B386.56%
2021-12-31HK$0.55 B8.72%
2020-12-31HK$0.51 B
2019-01-31HK$0.36 B15.04%
2018-01-31HK$0.31 B-7.39%
2017-01-31HK$0.34 B32.17%
2016-01-31HK$0.25 B30.17%
2015-01-31HK$0.19 B360.82%
2014-01-31HK$42.9 M-34.41%
2013-01-31HK$65.41 M64.69%
2012-01-31HK$39.71 M-37.37%
2011-01-31HK$63.41 M-47.51%
2010-01-31HK$0.12 B178.4%
2009-01-31HK$43.39 M-86.06%
2008-01-31HK$0.31 B-43.37%
2007-01-31HK$0.54 B76.71%
2006-01-31HK$0.31 B-20.57%
2005-01-31HK$0.39 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
HK$9.31 B 146.13%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
HK$1.89 B-49.86%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$0.75 B-79.94%๐Ÿ‡บ๐Ÿ‡ธ USA